Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology
- 2 January 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 104 (1), 124-133
- https://doi.org/10.1161/circresaha.108.176008
Abstract
Blockade of the renin–angiotensin–aldosterone system (RAAS) is being evaluated as a treatment for diabetic retinopathy; however, whether the mineralocorticoid receptor (MR) and aldosterone influence retinal vascular pathology is unknown. We examined the effect of MR antagonism on pathological angiogenesis in rats with oxygen-induced retinopathy (OIR). To determine the mechanisms by which the MR and aldosterone may influence retinal angiogenesis; inflammation and glucose-6-phosphate dehydrogenase (G6PD) were evaluated in OIR and cultured bovine retinal endothelial cells (BRECs) and bovine retinal pericytes (BRPs). In OIR, MR antagonism (spironolactone) was antiangiogenic. Aldosterone may mediate the pathogenic actions of MR in the retina, with 11β-hydroxysteroid dehydrogenase type 2 mRNA being detected and with aldosterone stimulating proliferation and tubulogenesis in BRECs and exacerbating angiogenesis in OIR, which was attenuated with spironolactone. The MR and aldosterone modulated retinal inflammation...Keywords
This publication has 37 references indexed in Scilit:
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialThe Lancet, 2008
- Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary VasculatureCirculation Research, 2007
- Retinopathy of prematurityAngiogenesis, 2007
- Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activityNature Medicine, 2007
- Retinal Dysfunction in Diabetic Ren-2 Rats Is Ameliorated by Treatment with Valsartan but Not AtenololPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2007
- NADPH Oxidases: New Regulators of Old FunctionsAntioxidants and Redox Signaling, 2006
- Combination Therapy with Aldosterone Blockade and Renin-Angiotensin Inhibitors Confers Organ ProtectionHypertension Research, 2006
- Two‐year results of laser treatment for retinopathy of prematurity at a single neonatal intensive care unitClinical & Experimental Ophthalmology, 2005
- Aldosterone/salt induces renal inflammation and fibrosis in hypertensive ratsKidney International, 2003
- Time course of enhanced adrenal responsiveness to angiotensin on a low salt diet.Hypertension, 1990